CBPO My Mistake 4 earlier post
China Biologic Products Approved to List on NASDAQ
TAI'AN, China, Dec. 1 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC:CBPO) (BULLETIN BOARD: CBPO) (NASDAQ:CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that the Company has received approval to list its common stock on the NASDAQ Global Market.
China Biologic expects its shares to begin trading on the NASDAQ on Wednesday, December 2, 2009, until which time its shares will continue to trade on the Over-the-Counter Bulletin Board. The Company's trading symbol will remain "CBPO."
